Phase 1b/2 trial of tepotinib in sorafenibpretreated advanced hepatocellular carcinoma with MET overexpression

Decaens, T; Barone, C; Assenat, E; Wermke, M; Fasolo, A; Merle, P; Blanc, JF; Grando, V; Iacobellis, A; Villa, E; Trojan, J; Straub, J; Bruns, R; Berghoff, K; Scheele, J; Raymond, E; Faivre, S

Decaens, T (corresponding author), Univ Grenoble Alpes, Dept Hepatogastroenterol & Digest Oncol, CHU Grenoble Alpes, Inst Adv Biosci,INSERM U1209, Grenoble, France.

BRITISH JOURNAL OF CANCER, 2021; 125 (2): 190

Abstract

Background This Phase 1b/2 study evaluated tepotinib, a highly selective MET inhibitor, in US/European patients with sorafenibpretreated advanced hepa......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索